The American Diabetes Association recently released major diabetes care updates, which include new recommendations on diabetes technology, therapy, and preventative health. The ADA's annual Standards ...

Food noise became a popular topic of conversation when people taking newer diabetes and weight loss drugs noticed that the medication quieted their thoughts about food. Researchers are still learning ...

Diabetes experts in research and technology addressed challenges around meals, exercise, device accuracy, and hypoglycemia. The panel explored advances in continuous glucose monitoring and automated ...

New guidance for leveraging diabetes technology during pregnancy has been published in a world-renowned medical journal. Recommendations were developed by medical experts from six continents, brought ...

Diabetes is the leading cause of kidney failure in the U.S., sending hundreds of thousands of people to dialysis or the transplant list. But for many, that outcome isn’t inevitable – there are proven ...

Type 2 diabetes is a chronic health condition in which the body has trouble processing glucose (or sugar) from the bloodstream to use for energy. It means your body isn’t using insulin effectively, ...

Diabetes is the leading cause of kidney failure in the U.S., sending hundreds of thousands of people to dialysis or the transplant list. But for many, that outcome isn’t inevitable – there are proven ...

Diabetes stigma includes the experiences of exclusion, rejection, prejudice, and blame that some people with diabetes encounter. Learn how to identify this stigma, how it can lead to worse health ...

Fully closed loop systems take automated insulin delivery a step further by skipping meal announcements. People with diabetes in the open source community are using fully closed loop systems, and ...

While an A1C blood test has long been the standard for assessing blood sugar management, it can often be inaccurate in people with diabetes. GMI is a metric that uses CGM data to estimate your A1C.

Medtronic’s MiniMed 780G automated insulin delivery system is FDA-cleared for use in people with type 1 diabetes ages 7 and above and adults (ages 18 and older) with type 2. The automated insulin ...

Unlike FDA-approved GLP-1 medications like Ozempic and Wegovy, dietary supplements like Lemme GLP-1 Daily do not require FDA approval or any data to support their marketing claims. Limited research ...